Top-News

GSK Glaxo Smith Kline Aktie (ADR) News

Aktie
WKN:  A3DMHS ISIN:  US37733W2044 US-Symbol:  GSK Branche:  Pharmazeutika Land:  Großbritannien
48,41 $
-0,16 $
-0,33%
41,576 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
82,88 Mrd. €
Streubesitz
80,80%
KGV
21,77
Dividende
0,42 $
Dividendenrendite
0,86%
Faktor
0.5
Originalaktie
GB00BN7SWP63

GSK Glaxo Smith Kline Aktie (ADR) News

19.02.25 - PR Newswire
GSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
GSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
18.02.25 - PR Newswire
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit PR Newswire
18.02.25 - PR Newswire
GSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
GSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
18.02.25 - PR Newswire
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
18.02.25 - PR Newswire
GSK plc Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK
GSK plc Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK PR Newswire
16.02.25 - PR Newswire
GSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PR Newswire
14.02.25 - PR Newswire
Shareholder Rights Law Firm Robbins LLP Reminds GSK Investors with Large Losses to Seek Advice on Leading the GSK PLC Class Action
Shareholder Rights Law Firm Robbins LLP Reminds GSK Investors with Large Losses to Seek Advice on Leading the GSK PLC Class Action PR Newswire
14.02.25 - PR Newswire
Shareholders of GSK plc Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK
Shareholders of GSK plc Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK PR Newswire
13.02.25 - PR Newswire
Class Action Filed Against GSK plc (GSK) Seeking Recovery for Investors - Contact The Gross Law Firm
Class Action Filed Against GSK plc (GSK) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire
13.02.25 - PR Newswire
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
12.02.25 - PR Newswire
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit PR Newswire
11.02.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK PR Newswire
11.02.25 - PR Newswire
Investors who lost money on GSK plc(GSK) should contact Levi & Korsinsky about pending Class Action - GSK
Investors who lost money on GSK plc(GSK) should contact Levi & Korsinsky about pending Class Action - GSK PR Newswire
10.02.25 - PR Newswire
GSK plc Class Action: The Gross Law Firm Reminds GSK Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - GSK
GSK plc Class Action: The Gross Law Firm Reminds GSK Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - GSK PR Newswire
07.02.25 - PR Newswire
GSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PR Newswire
06.02.25 - PR Newswire
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit PR Newswire
05.02.25 - PR Newswire
Investor Alert: Robbins LLP Informs Stockholders of the GSK PLC Class Action
Investor Alert: Robbins LLP Informs Stockholders of the GSK PLC Class Action PR Newswire

Newssuche

Videos

newspaper
05.12.25 +1,73%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »